140. Ruiz C, Lenkiewicz E, L, et al. Advancing a clinically relevant perspective of the clonal nature of cancer. 2011;108:12054–12059. Proc Natl Acad Sci U S A. 141. Remmers N, Anderson JM, Linde EM, et al. Aberrant expression of mucin core proteins and glycans associated with progression of pancreatic cancer. o-linked Clin Cancer Res. 2013;19: 1981–1993. 142. Ingkakul T, Sadakari Y, Ienaga J, et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. 2010; Ann Surg. 251:70–75. 143. Feng Z, J, Pepe M, et al. The Early Detection Research Network's specimen reference sets: paving the way for rapid evaluation of potential biomarkers. 2013;59:68–74. Clin Chem.
140. Ruiz C, Lenkiewicz E, L, et al. Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci U S A. 2011;108:12054–12059. 141. Remmers N, Anderson JM, Linde EM, et al. Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer. Clin Cancer Res. 2013;19: 1981–1993. 142. Ingkakul T, Sadakari Y, Ienaga J, et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010; 251:70–75. 143. Feng Z, J, Pepe M, et al. The Early Detection Research Network's specimen reference sets: paving the way for rapid evaluation of potential biomarkers. Clin Chem. 2013;59:68–74.